Next 10 |
home / stock / ntra / ntra articles
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 19.2% on an annualized basis producing an average annual return of 32.67%...
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 20.26% on an annualized basis producing an average annual return of 33.37...
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management expects Amazon.com, Inc. (NASDAQ:AMZN) to go ...
The Nasdaq 100 closed higher by around 1% on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it co...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...
U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday. Shares of Genpact Limited (NYSE:G) rose sharply during Friday...
Shares of Natera, Inc. (NASDAQ:NTRA) rose sharply in today's pre-market trading following strong first-quarter earnings. Natera posted GAAP lo...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th International Conference on Prenatal Diagnosis and Therapy. Hosted by the Internationa...
First-of-its-kind study in gastroesophageal adenocarcinoma using Signatera to guide treatment and assess the efficacy of a novel HER2-directed adjuvant treatment Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new gastroes...
2024-06-23 13:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...